We developed CRISPR-U™ (based on CRISPR/Cas9 technology) which is more efficient than general CRISPR/Cas9 in double-strand breaking, and CRISPR-U™ can greatly improve the efficiency of homologous recombination, easily achieve knockout (KO), point mutation (PM) and knockin (KI) in vitro and in vivo. With CRISPR-U™, Ubigene has successfully edit genes on more than 100 cell lines.
Thursday, June 11, 2020
CRISPR-U Genome-editing technologies | High-efficiency
标签:
COVID-19,
CRISPR,
Knockout cell
Ubigene Biosciences, is a fast-growing company with an experienced team in gene-editing. Our advanced molecular and cell biology platform ensure us to provide high-quality services and products for biological research and biotechnology industries.
Subscribe to:
Post Comments (Atom)
[Research highlight] Enhancing p53 pathway can efficiently suppress colon cancer
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
-
Background In 1996, U-87 MG cell line was isolat ed from the malignant glioma of a 44-year-old female patient. This human primary gliob...
-
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
No comments:
Post a Comment